Top 10 ODT Articles from 2023

This past year was big for FDA approvals of orthopedic devices and new CEO appointments. 
 
The FDA gave Stryker 510(k) clearance for its Pangea systems as well as clearance for Moximed’s MISHA knee system. 
 
Orthofix appointed Massimo Calafiore as its new president and CEO. Calafiore previously served as CEO to LimaCorporate S.p.A., and he also joins Orthofix’s Board of Directors. This appointment followed the termination of Keith Valentine, John Bostjancic, and Patrick Keran due to “engagement in reported inappropriate and offensive conduct.”
 
Acqusitions were also a popular topic this year as Zimmer Biomet acquired Embody Inc. in January, and Stryker began purchasing SERF SAS, the inventor of the Dual Mobility Cup. 
 
 

1. The 2023 Top 10 Orthopedic Device Companies
2. Spineart, eCential Robotics Begin Partnership
3. Massimo Calafiore Named Orthofix President and CEO
4. Orthofix Top Execs Fired for Harassment, ‘Inappropriate Conduct’
5. Stryker’s Pangea Systems Earn FDA Nod
6. Stryker to Buy SERF SAS, Inventor of the Dual Mobility Hip Cup
7. AMETEK to Purchase Paragon Medical for ~$2 Billion
8. Angry@Arthritis Rolls Out Global Osteoarthritis Clinical Trial Locator
9. FDA OKs Moximed’s MISHA Shock Absorber for Knee OA
10. Zimmer Biomet Holdings Agrees to Acquire Embody Inc.